Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and β2 -microglobulin in multiple myeloma-Reference-Cited by-同舟云学术

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and β2 -microglobulin in multiple myeloma

Published:2003-01 Issue:1 Volume:70 Page:34-42
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Terpos Evangelos,Viniou Nora,De La Fuente Josu,Meletis John,Voskaridou Ersi,Karkantaris Christos,Vaiopoulos George,Palermos John,Yataganas Xenophon,Goldman John M,Rahemtulla Amin

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2003.02823.x/fullpdf

Reference35 articles.

1. New advances in the biology and treatment of myeloma bone disease;Berenson;Semin Hematol,2001

2. Role of cytokines in multiple myeloma;Anderson;Semin Hematol,1999

3. Regulation of osteoclast function;Suda;J Bone Miner Res,1997

4. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity;Shipman;Br J Haematol,1997

5. Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines;Tassone;Leukemia,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clodronate detection and effects on markers of bone resorption are prolonged following a single administration to horses;Equine Veterinary Journal;2022-08-23

2. Heme oxygenase‐1 attenuates the inhibitory effect of bortezomib against the APRIL‐NF‐κB‐CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma;Journal of Cellular Biochemistry;2018-10-28

3. Bisphosphonates in multiple myeloma: an updated network meta-analysis;Cochrane Database of Systematic Reviews;2017-12-18

4. Tartrate-Resistant Acid Phosphatase as a Biomarker of Bone Remodeling;Biomarkers in Bone Disease;2017

5. Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials;Pharmacology & Therapeutics;2016-02